摘要
新型冠状病毒肺炎(coronavirus disease 2019,COVID-19)是一种急性感染性呼吸道疾病,关于超短波透热疗法(ultrashort wave diathermy,USWD)治疗COVID-19,目前有康复诊疗共识建议采用,也有专家共识并未推荐。由于COVID-19的致病病毒是一种新型病毒,相关研究较少,因此该文总结了USWD治疗病毒性肺炎的研究证据及可能机制,进而探讨USWD治疗COVID-19需要考虑的因素。该文认为,在获得高质量的研究证据之前,在对COVID-19的发病机制与疾病发展认识有限的情况下,应谨慎使用USWD治疗COVID-19。为USWD治疗COVID-19提供科学的实践研究证据可能是目前急需解决的问题。
Coronavirus disease 2019(COVID-19) is an acute infectious respiratory disease. Ultrashort wave diathermy(USWD) for COVID-19 is recommended by some consensuses on COVID-19 rehabilitation diagnosis and treatment, while it is not mentioned in some other experts consensuses. Because the virus that causes COVID-19 is new and there are few related studies, this paper summarizes the research evidence and possible mechanisms of USWD in the treatment of viral pneumonia, and discusses the factors that need to be considered in the treatment of COVID-19. In this paper, it is suggested that before high-quality research evidence being obtained and under the condition of limited understanding of the pathogenesis and disease development of COVID-19, the application of USWD in COVID-19 should be cautious. To provide scientific and practical research evidence for the treatment of COVID-19 by USWD may be an urgent problem to be solved at present.
作者
姜俊良
王丽琼
宋康平
何成奇
JIANG Junliang;WANG Liqiong;SONG Kangping;HE Chengqi(Rehabilitation Medicine Center,West China Hospital,Sichuan University,Chengdu,Sichuan 610041,P.R.China;Rehabilitation Medicine Key Laboratory of Sichuan Province,Chengdu,Sichuan 610041,P.R.China;Institute for Disaster Management and Reconstruction,Sichuan University-The Hong Kong Polytechnic University,Chengdu,Sihcuan 610207,P.R.China)
出处
《华西医学》
CAS
2020年第5期534-537,共4页
West China Medical Journal
基金
国家自然科学基金(81972146)。
